Terebellum

Trending Articles

  1. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. ChargePoint invest in a single-use manufacturing facility to expand product line The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
  4. COVID-19 still a significant risk for the immunocompromised, study finds AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
  5. Broughton receives flexible scope ISO 17025 accreditation New certification allows accreditation without prior approval

Upcoming event

ASGCT Annual Meeting 2024

7-11 May, 2024 | Meeting | Portland, OR See all

Related Content

Manufacturing

Terebellum adopts name of global parent AscellaHealth

Adopting the brand name of its parent company, AscellaHealth, will enable the specialty pharma expert to demonstrate its full range of expertise
Marketing

Seven specialty pharmacy trends for 2023

Terebellum, a global healthcare and specialty pharmacy solutions company, has released its list of industry trends to watch out for in 2023. These include numerous positive developments that impact all stakeholders in the specialty pharmacy/rare disease ecosystem and care continuum that spans patients, payers, life sciences manufacturers and providers
Research & Development

How soon is too soon to consider market access strategies for my specialty drug?

The answer is that it’s never too soon, advises Craig Caceci, Managing Director at Terebellum. In fact, he says, if you want to ensure your product is paid for, then the sooner the better
Manufacturing

Terebellum announces partnership with NeurosolvTherapeutics

The partnership is a bid to support the launch of Perineline, a new patented two-part therapy
Subscribe now